Keyphrases
Asthma
100%
Monotherapy
100%
Inhaled Corticosteroids
100%
Frequent Use
100%
Long-acting beta-agonists
100%
Relative Risk
44%
Life-threatening
33%
Hospitalization
33%
Salmeterol
33%
Asthma Mortality
33%
Detrimental Effects
22%
Protective Effect
22%
High Risk
11%
Placebo
11%
Reinforced
11%
AstraZeneca
11%
Novartis
11%
Combined Therapy
11%
Randomized Clinical Trial
11%
Non-fatal
11%
Corticosteroids
11%
Risk of Death
11%
International Recommendations
11%
MEDLINE
11%
Embase
11%
Subgroup Analysis
11%
Treatment Duration
11%
Serious Adverse Events
11%
Asthma Exacerbation
11%
Cochrane
11%
Asthma Control
11%
Concomitant Use
11%
Add-on Therapy
11%
Clinical Database
11%
Persistent Asthma
11%
Severe Outcomes
11%
Child Patients
11%
Systemic Corticosteroids
11%
Serious Adverse Effects
11%
Formoterol
11%
GlaxoSmithKline
11%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Monotherapy
100%
Beta Adrenergic Receptor Stimulating Agent
100%
Salmeterol
33%
Adverse Event
22%
Corticosteroid
11%
Randomized Clinical Trial
11%
Clinical Trial
11%
Add on Therapy
11%
Disease
11%
Placebo
11%
Formoterol
11%